Legislative Research: US SB4303 | 2021-2022 | 117th Congress

Other Sessions

SessionTitle/DescriptionLast Action
2021-2022
117th Congress

(Introduced - Dead)
A bill to provide for a period of exclusivity for first interchangeable biological products.
[SB4303 2021 Detail][SB4303 2021 Text][SB4303 2021 Comments]
2022-05-25
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)
2019-2020
116th Congress

(Introduced - Dead)
A bill to improve State short-term compensation programs, and for other purposes.
[SB4303 2019 Detail][SB4303 2019 Text][SB4303 2019 Comments]
2020-07-23
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4474-4475)

References Online

Search PhraseWebNewsFinancialFinancialEncylopediaBiographyBioGuide
[US Congress SB4303]Google WebGoogle News
[US Congress Senate Health, Education, Labor, And Pensions Committee]Google WebGoogle NewsN/A
[Senator Tim Kaine US]Google WebGoogle NewsOpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
[Senator Susan Collins US]Google WebGoogle NewsOpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide
[Senator Margaret Hassan US]Google WebGoogle NewsOpenSecretsFollowTheMoneyBallotpediaVoteSmartBioGuide

Legislative Citation

APA
US SB4303 | 2021-2022 | 117th Congress. (2022, May 25). LegiScan. Retrieved May 01, 2024, from https://legiscan.com/US/bill/SB4303/2021
MLA
"US SB4303 | 2021-2022 | 117th Congress." LegiScan. LegiScan LLC, 25 May. 2022. Web. 01 May. 2024. <https://legiscan.com/US/bill/SB4303/2021>.
Chicago
"US SB4303 | 2021-2022 | 117th Congress." May 25, 2022 LegiScan. Accessed May 01, 2024. https://legiscan.com/US/bill/SB4303/2021.
Turabian
LegiScan. US SB4303 | 2021-2022 | 117th Congress. 25 May 2022. https://legiscan.com/US/bill/SB4303/2021 (accessed May 01, 2024).

Subjects


Same As/Similar To

BillRelationshipDateTitleLast Action
SB4348Related2022-07-13Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

US Congress State Sources


feedback